Terms: = Lymphoma AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
133 results:
1. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract] [Full Text] [Related]
2. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract] [Full Text] [Related]
3. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
4. Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors.
Hayashi T; Tateishi K; Matsuyama S; Iwashita H; Miyake Y; Oshima A; Honma H; Sasame J; Takabayashi K; Sugino K; Hirata E; Udaka N; Matsushita Y; Kato I; Hayashi H; Nakamura T; Ikegaya N; Takayama Y; Sonoda M; Oka C; Sato M; Isoda M; Kato M; Uchiyama K; Tanaka T; Muramatsu T; Miyake S; Suzuki R; Takadera M; Tatezuki J; Ayabe J; Suenaga J; Matsunaga S; Miyahara K; Manaka H; Murata H; Yokoyama T; Tanaka Y; Shuto T; Ichimura K; Kato S; Yamanaka S; Cahill DP; Fujii S; Shankar GM; Yamamoto T
Clin Cancer Res; 2024 Jan; 30(1):116-126. PubMed ID: 37851071
[TBL] [Abstract] [Full Text] [Related]
5. A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
Ludvigsen LUP; Andersen AS; Hamilton-Dutoit S; Jensen-Fangel S; Bøttger P; Handberg KJ; Ivarsen P; d'Amore F; Bibby BM; Albertsen BK; Jespersen B; Thomsen MK
J Clin Virol; 2023 Oct; 167():105579. PubMed ID: 37683299
[TBL] [Abstract] [Full Text] [Related]
6. Rosai-Dorfman disease of the breast: a clinicoradiologic and pathologic study.
Wang Q; Bradley K; Zhang M; Li S; Li X
Hum Pathol; 2023 Nov; 141():30-42. PubMed ID: 37673345
[TBL] [Abstract] [Full Text] [Related]
7. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract] [Full Text] [Related]
8. Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
9. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
10. Lung adenocarcinoma harboring complex EML4-ALK fusion and braf V600E co-mutation responded to alectinib.
Guo W; Liang J; Zhang D; Huang X; Lv Y
Medicine (Baltimore); 2022 Oct; 101(40):e30913. PubMed ID: 36221356
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.
Soo R; Mery L; Bardot A; Kanesvaran R; Keong TC; Pongnikorn D; Prasongsook N; Hutajulu SH; Irawan C; Manan AA; Thiagarajan M; Sripan P; Peters S; Storm H; Bray F; Stahel R
ESMO Open; 2022 Oct; 7(5):100560. PubMed ID: 35988454
[TBL] [Abstract] [Full Text] [Related]
12. Response to treatment with an ALK-TKI in a patient with advanced lung adenocarcinoma with concurrent ALK fusion and high PD-L1 expression: A case report.
Zhang Y; Fang H; Hong J; Wang X; Wang H; Pan G
Medicine (Baltimore); 2022 Aug; 101(33):e30094. PubMed ID: 35984185
[TBL] [Abstract] [Full Text] [Related]
13. Primary pulmonary epithelial-myoepithelial carcinoma: Report of a rare and under-diagnosed low-grade malignancy.
Sharma S; Tayal A; Khatri S; Mohapatra SG; Mohanty SK
J Cancer Res Ther; 2022; 18(3):795-800. PubMed ID: 35900560
[TBL] [Abstract] [Full Text] [Related]
14. Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.
Liu C; Liu C; Liao J; Yin JC; Wu X; Zhao X; Sun S; Wang H; Hu Z; Zhang Y; Yu H; Shao Y; Wang J
Lung Cancer; 2022 Sep; 171():18-25. PubMed ID: 35870258
[TBL] [Abstract] [Full Text] [Related]
15. Targeting molecular alterations in non-small-cell lung cancer: what's next?
López-Castro R; García-Peña T; Mielgo-Rubio X; Riudavets M; Teixidó C; Vilariño N; Couñago F; Mezquita L
Per Med; 2022 Jul; 19(4):341-359. PubMed ID: 35748237
[TBL] [Abstract] [Full Text] [Related]
16. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
Coutant M; Lhermitte B; Guérin E; Chammas A; Reita D; Sebastia C; Douzal V; Gabor F; Salmon A; Chenard MP; Todeschi J; Coca A; Heng MA; Vincent F; Entz-Werlé N
Pediatr Blood Cancer; 2022 Aug; 69(8):e29575. PubMed ID: 35373885
[TBL] [Abstract] [Full Text] [Related]
17. Lack of Increased Risk of lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases.
Kobayashi T; Udagawa E; Hibi T
Digestion; 2022; 103(2):169-173. PubMed ID: 34983046
[TBL] [Abstract] [Full Text] [Related]
18. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract] [Full Text] [Related]
19. [Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network].
de la Fouchardière C; Wassermann J; Calcagno F; Bardet S; Al Ghuzlan A; Borget I; Borson Chazot F; Do Cao C; Buffet C; Zerdoud S; Decaussin-Petrucci M; Godbert Y; Leboulleux S
Bull Cancer; 2021 Nov; 108(11):1044-1056. PubMed ID: 34593218
[TBL] [Abstract] [Full Text] [Related]
20. Characteristics and outcomes of 727 patients with mycosis fungoides and Sézary syndrome from a Brazilian cohort.
Miyashiro D; Sanches JA
Int J Dermatol; 2022 Apr; 61(4):442-454. PubMed ID: 34435672
[TBL] [Abstract] [Full Text] [Related]
[Next]
